1. Hepatotoxicity following systemic therapy for colorectal liver metastases and the impact of chemotherapy-associated liver injury on outcomes after curative liver resection
   G. Duwe et al, 2017, European Journal of Surgical Oncology CrossRef
2. Contribution of Piezo2 to Endothelium-Dependent Pain
   Luiz F. Ferrari et al, 2015, Molecular Pain CrossRef
3. Extravasated platelet aggregation in the livers of rats with drug-induced hepatic sinusoidal obstruction syndrome
   Miki Hirata et al, 2017, Molecular Medicine Reports CrossRef
4. Targeting Platelets for the Treatment of Cancer
   Omar Elaskalani et al, 2017, Cancers CrossRef
5. Oxaliplatin-induced hepatic sinusoidal obstruction syndrome
   Chen Zhu et al, 2021, Toxicology CrossRef
6. Phosphodiesterase III inhibitor attenuates rat sinusoidal obstruction syndrome through inhibition of platelet aggregation in Disse's space
   Takashi Miyata et al, 2018, Journal of Gastroenterology and Hepatology CrossRef
7. The Provocative Roles of Platelets in Liver Disease and Cancer
   Preeti Kanikarla Marie et al, 2021, Frontiers in Oncology CrossRef
8. Model establishment and microarray analysis of mice with oxaliplatin‑induced hepatic sinusoidal obstruction syndrome
   Chen Zhu et al, 2022, Molecular Medicine Reports CrossRef
9. Assaying ADAMTS13 Activity as a Potential Prognostic Biomarker for Sinusoidal Obstruction Syndrome in Mice
   Masakazu Saeki et al, 2023, International Journal of Molecular Sciences CrossRef
10. Esophagogastric varices were diagnosed in a non-cirrhotic liver case during long-term follow-up after oxaliplatin-based chemotherapy
    Ryuta Shigefuku et al, 2018, Clinical Journal of Gastroenterology CrossRef
11. Role of 7-chloro-4-(phenylselanyl) quinoline in the treatment of oxaliplatin-induced hepatic toxicity in mice
    Briana B. Lemos et al, 2021, Canadian Journal of Physiology and Pharmacology CrossRef
12. The use of defibrotide in blood and marrow transplantation
    Paul G. Richardson et al, 2018, Blood Advances CrossRef
13. Application Progress of Gd-EOB-DTPA-Enhanced MRI T1 Mapping in Hepatic Diffuse Diseases
    Long Xu et al, 2022, Current Medical Imaging Reviews CrossRef
14. Liver Microvascular Injury and Thrombocytopenia of Antibody–Calicheamicin Conjugates in Cynomolgus Monkeys—Mechanism and Monitoring
    Magali Guffroy et al, 2017, Clinical Cancer Research CrossRef
15. Platelets prevent the development of monocrotaline-induced liver injury in mice
    Fumisato Otaka et al, 2020, Toxicology Letters CrossRef
16. The hepatoprotective role of reduced glutathione and its underlying mechanism in oxaliplatin-induced acute liver injury
    Youzhi Lin et al, 2017, Oncology Letters CrossRef
17. Defibrotide for Sinusoidal Obstruction Syndrome and Nodular Regenerative Hyperplasia After Oxaliplatin-Based Hepatic Intra-Arterial Chemotherapy: A Case Report
    Amaury Druet et al, 2022, Clinical Colorectal Cancer CrossRef
18. Editorial for “T1 Mapping on Gd‐EOB‐DTPA‐Enhanced MRI for the Prediction of Oxaliplatin‐Induced Liver Injury in a Mouse Model”
    Sikandar Shaikh, 2021, Journal of Magnetic Resonance Imaging CrossRef
19. Thrombopoietin accumulation in hepatocytes induces a decrease in its serum levels in a sinusoidal obstruction syndrome model
    Hiroto Yamazaki et al, 2022, Molecular Medicine Reports CrossRef
20. Isolinderalactone Resistance to the Liver Injury Induced by Oxaliplatin in Rats Through Inhibiting IL-6/STAT3 Signal Pathway
    Rongwei Lin et al, 2023, Anti-Cancer Agents in Medicinal Chemistry CrossRef
21. Oxaliplatin‑induced changes in splenic volume and liver fibrosis indices: retrospective analyses of colon cancer patients receiving adjuvant chemotherapy
    Kadriye Bir Yücel et al, 2024, Journal of Chemotherapy CrossRef